Ross Stores vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 78)

Ross Stores

LeaderConsumer Retail

Enterprise

Dublin CA largest US off-price retailer (NASDAQ: ROST) at $21.1B FY2024 sales (+3.7%), $2.1B net income; 2,273 stores expanding to 2,900 Ross + 700 dd's target competing with TJX Companies for off-price apparel shoppers.

AI VisibilityBeta
Overall Score
B78
Category Rank
#281 of 290
AI Consensus
55%
Trend
stable
Per Platform
ChatGPT
87
Perplexity
80
Gemini
70

About

Ross Stores, Inc. is a Dublin, California-based off-price variety retailer — publicly traded on NASDAQ (NASDAQ: ROST) as an S&P 500 Consumer Discretionary component — operating two retail banners: Ross Dress for Less (name-brand and designer apparel, footwear, and home fashion at 20-60% below department store prices) and dd's DISCOUNTS (20-70% below moderate department store prices for more budget-conscious shoppers) through approximately 107,000 employees. In fiscal year 2024, Ross Stores reported $21.1 billion in total sales (up 3.7% year-over-year), net earnings of $2.1 billion, and EPS of $6.32 (versus $5.56 in fiscal 2023), opening 89 new stores (75 Ross, 14 dd's) to end FY2024 with 2,205 total stores. As of 2025, Ross operates 2,273 stores across 44 states, Washington D.C., Guam, and Puerto Rico with long-term expansion targets of 2,900 Ross Dress for Less and 700 dd's DISCOUNTS locations. Founded in 1950 as a small department store chain in San Bruno, California, Ross transformed into an off-price retailer in 1982 under new management and grew into the largest US off-price retailer by revenue. The company sources merchandise through buying offices in New York City, Los Angeles, and Boston, accessing manufacturer overruns, retail liquidations, and closeout opportunities from thousands of vendors and brand partners. Seven distribution centers support the nationwide store network.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

78
Overall Score
90
#281
Category Rank
#9
55
AI Consensus
60
stable
Trend
stable
87
ChatGPT
99
80
Perplexity
99
70
Gemini
83
69
Claude
96
74
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.